Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  Pharmaron Beijing Co., Ltd.    300759   CNE100003JW4

PHARMARON BEIJING CO., LTD.

(300759)
  Report
 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
11/23/2020 11/24/2020 11/25/2020 11/26/2020 11/27/2020 Date
99 96.03 96.07 94.43 94.88 Last
6039049 7652153 6800112 5928683 2831478 Volume
-3.77% -3.00% +0.04% -1.71% +0.48% Change
Financials
Sales 2020 5 145 M 783 M 783 M
Net income 2020 998 M 152 M 152 M
Net cash position 2020 2 889 M 439 M 439 M
P/E ratio 2020 77,8x
Yield 2020 0,23%
Sales 2021 6 578 M 1 001 M 1 001 M
Net income 2021 1 153 M 175 M 175 M
Net cash position 2021 3 000 M 456 M 456 M
P/E ratio 2021 60,7x
Yield 2021 0,29%
Capitalization 73 444 M 11 166 M 11 172 M
EV / Sales 2020 13,7x
EV / Sales 2021 10,7x
Nbr of Employees -
Free-Float 83,1%
More Financials
Company
Pharmaron Beijing Co., Ltd. is a China-based company that provides research and manufacturing services throughout the discovery, development and manufacturing spectrum for small molecule drugs, cell therapies and gene therapies as well as providing testing services for medical devices and clinic research. The Company has four segments. The Laboratory Services segment includes laboratory chemistry, drug metabolism... 
More about the company
All news about PHARMARON BEIJING CO., LTD.
11/09PHARMARON BEIJING : Acquires Absorption Systems in the USA
BU
09/22PHARMARON BEIJING : Update announcement in relation to connected transaction est..
PU
09/21PHARMARON BEIJING : 2020 interim report
PU
08/28PHARMARON BEIJING : Inside information announcement
PU
08/24PHARMARON BEIJING CO., LTD. : half-yearly earnings release
08/11PHARMARON BEIJING : Supplemental announcement in relation to the annual report f..
PU
07/28PHARMARON BEIJING : List of directors and their roles and functions of the secon..
PU
07/23PHARMARON BEIJING : (i) poll results of the second extraordinary general meeting..
PU
04/14PHARMARON BEIJING : Mindset Pharma Begins Work with Leading R&D Contractor for N..
AQ
03/25PHARMARON BEIJING CO., LTD. : annual earnings release
More news
News in other languages on PHARMARON BEIJING CO., LTD.
08/24PHARMARON BEIJING CO., LTD. : Veröffentlichung des Halbjahresergebnisses
08/24PHARMARON BEIJING CO., LTD. : publication des résultats semestriels
03/25PHARMARON BEIJING CO., LTD. : Veröffentlichung des Jahresergebnisses
03/25PHARMARON BEIJING CO., LTD. : publication des résultats annuels
More news
Chart PHARMARON BEIJING CO., LTD.
Duration : Period :
Pharmaron Beijing Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHARMARON BEIJING CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Average target price 116,65 CNY
Last Close Price 94,88 CNY
Spread / Highest target 37,0%
Spread / Average Target 22,9%
Spread / Lowest Target 4,62%
EPS Revisions
Managers
NameTitle
Bo Liang Lou Chairman & Chief Executive Officer
Kexin Yang Chairman-Supervisory Board & Vice President
Xiao Qiang Lou Chief Operating Officer & Executive Director
Shing Chung Li Chief Financial Officer & Board Secretary
Hua Yang Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
PHARMARON BEIJING CO., LTD.83.22%11 166
LONZA GROUP AG55.15%44 901
MODERNA, INC.549.44%43 204
CELLTRION, INC.82.04%39 811
IQVIA HOLDINGS INC.9.26%32 568
SEAGEN INC.48.01%29 832